← All trials
NCT00347269
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2006
- Primary completion
- Oct 1, 2009
- Completion date
- Oct 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 1004
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of WashingtonLead sponsor
- University of WashingtonOverall official - principal investigator
- University of California, Los AngelesOverall official - principal investigator
- RAND CorporationOverall official - principal investigator
- University of California, San DiegoOverall official - principal investigator
- Hoosier Cancer Research NetworkOverall official - principal investigator
- University of WashingtonStudy director
- National Institute of Mental Health (NIMH)Collaborator
- University of WashingtonReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.